Moderna Biopharma Canada Corporation
Registration:
1
of
1
(2024-11-28
to
present)
Details Regarding the Identified Subject Matter
|
Specific Topics of Lobbying Communications
|
Intended Outcomes
|
Associated Subject Matters
|
Prioritize and expand access to adult and pediatric vaccines, recognizing their positive economic and health system benefits collaborate in British Columbia on health research (including clinical trials) and other partnerships.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
COVID-19, Economic Development and Trade, Government Procurement, Health, Hospitals, Indigenous Relations and Reconciliation, Science and Technology, Senior Citizens
|